Sala Pacinotti, 19/05/2017, 14:30 - 16:00
COMUNICAZIONI 1
MODERATORE: FRANCESCO CURTO
MODERATORE:
F. DI TONNO
MODERATORE:
E. MEREU
Bersaglio Prostata 1
Moderatori: F. Curto; F. Di Tonno; E. Mereu
TRENDS IN PSA TESTING, PROSTATE BIOPSIES AND RADICAL PROSTATECTOMY PROCEDURES IN MARCHE REGION
MRI-based nomogram to predict the probability of Prostate Cancer diagnosis with MRI-US fusion biopsy
MRI-based nomogram predicting the probability of diagnosing a clinically significant Prostate Cancer with MRI-US fusion biopsy
Evauation of PIRADS 3 lesion with sotware fiosn biopsies
Diagnostic performance of multiparametric MRI in prostate cancer: per core analysis of three prospective ultrasound/MRI fusion biopsy datasets
Self-learning in robot-assisted laparoscopic radical prostatectomy. Intraoperative outcomes and initial experience without any assistance from a tutor
FOCAL TREATMENT OF PROSTATE CANCER USING FOCAL ONE DEVICE. ROLE OF FOCAL THERAPY, ONCOLOGICAL AND FUNCTIONAL RESULTS
The diagnostic and staging performance of mpMRI/US guided fusion prostate biopsy: prospective analysis on 41 consecutive whole mount radical prostatectomy specimens
ECONOMICAL IMPLICATIONS OF THE INTRODUCTION OF AN ALTERNATIVE TREATMENT MODALITY FOR PROSTATE CANCER (HIGH INTENSITY FOCUS ULTRASOUND) IN A MULTIDISCIPLINARY TEAM
SALVAGE HIGH INTENSITY FOCUS ULTRASOUND (HIFU) FOLLOWING PRIMARY HIFU FOR PROSTATE CANCER HAS TO BE CONSIDERED AS AN ALTERNATIVE TREATMENT FOR RECURRENCE
COMPARISON OF TWO TEMPLATES OF LYMPHADENECTOMY IN PATIENTS AFFECTED BY HIGH RISK PROSTATE CANCER
PROGNOSITC FACTORS OF NODAL METASTASIS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER
Salvage lymph node dissection for nodal recurrence after radical prostatectomy
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer in chemotherapy-naive patients: an Italian multicentre “real life” 1 year study